PRA Health Sciences
- Address
- lock Available on a paid plan
Neoplasms
The site conducts research in ER+/HER2- breast cancer, aiming to compare oral tablet and IV infusion delivery and to understand drug uptake in the bloodstream.
- Oral versus intravenous administration
- Pharmacokinetic profiling in healthy adults
- Targeted hormone‑responsive tumor mechanisms
PRA Health Sciences leverages its oncology expertise to advance treatment options for hormone‑responsive tumors.
Population Characteristics
Studies target obesity by evaluating the safety, absorption, and elimination of novel compounds in healthy volunteers.
- Safety assessment of new metabolic agents
- Absorption and elimination profiling
- Metabolic and population health insights
The Groningen location supports population health research to improve therapeutic strategies for metabolic conditions.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in PRA Health Sciences
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase I Study to Evaluate the Safety, Pharmacokinetics, and Absorption of RO7795068 in Subjects with Obesity | F. Hoffmann-La Roche AG | Phase I | Not Recruiting | Mar 2026 | Jul 2026 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.